4.7 Article

Hospital readmission in systemic sclerosis associated pulmonary hypertension: Results from the PHAROS registry

Journal

RHEUMATOLOGY
Volume 61, Issue 4, Pages 1510-1517

Publisher

OXFORD UNIV PRESS
DOI: 10.1093/rheumatology/keab569

Keywords

SSc; pulmonary hypertension; hospitalization; readmission; morbidity; scleroderma

Categories

Funding

  1. Scleroderma Foundation
  2. Mackley Foundation
  3. Actelion Pharmaceuticals
  4. Gilead Sciences
  5. Weill Cornell Medicine Clinical and Translational Science Center [UL1 TR002384]

Ask authors/readers for more resources

This study identified predictors of hospital readmission among individuals with SSc-associated pulmonary hypertension (SSc-PH). The strongest predictor was the reason for the initial hospitalization being related to PH. Home oxygen use was associated with a lower likelihood of readmission.
Objective To identify individual-level factors associated with hospital readmission among individuals with SSc-associated pulmonary hypertension (SSc-PH). Methods Individuals enrolled in the Pulmonary Hypertension Assessment and Recognition of Outcomes in Scleroderma (PHAROS) registry contributed clinical data related to SSc-PH disease severity and hospital admissions. Readmission was defined as a subsequent hospitalization within 12 months of any hospital discharge. Characteristics were compared between individuals with and without readmissions using Fisher's exact test, Wilcoxon rank-sum test, or Kruskal-Wallis test. Logistic regression was used to estimate associations between clinical predictors and likelihood of readmission. Results Of 572 individuals with SSc-PH enrolled in PHAROS, 54% had >= 1 hospitalizations between 2005 and 2016. Among individuals ever-hospitalized, 34% had >= 1 readmission. Individuals with vs without readmissions had shorter median (IQR) time between index hospitalization date and next PHAROS visit [37 (3, 80) vs 81 (42, 136) days, P <0.001]. Index admissions related to PH or SSc (vs non-PH/SSc related) were associated with an increased odds of 12-month readmission [aOR 6.6 (95% CI 3.2, 13.6) and aOR 2.2 (95% CI 1.1, 4.5), respectively]. Readmission was less likely among home oxygen users (vs non-users) (aOR 0.44; 95% CI 0.22, 0.89). Race, age, sex, disease duration and disease subtype were not associated with readmission. Conclusion The strongest predictor for 12-month readmission was an index hospitalization reason related to PH. Home oxygen use was associated with lower odds of readmission. Future studies should determine whether testing for the need for home oxygen mediates the risk of readmission in SSc-PH.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available